跳至主要内容
临床试验/NCT06779552
NCT06779552招募中不适用

CardioMEMS HF System Coverage with Evidence Development Study

Abbott Medical Devices1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2025年2月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
HF Hospitalization Rate.

研究概览

简要总结

The purpose of the CardioMEMS CED Study is to determine if pulmonary artery (PA) pressure-guided heart failure management using the CardioMEMS™ HF System improves long-term health outcomes in heart failure (HF) patients in the real-world setting.

详细描述

The CardioMEMS CED Study will assess 2-year HF hospitalization rates and survival for all-cause mortality in heart failure subjects managed with the CardioMEMS HF system, as compared to a contemporaneous control of HF subjects managed without PA pressure-guidance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject implanted with a CardioMEMS pressure sensor (treatment arm only)
  • Subject >=18 years of age at time of implant
  • Subject has a history of acute decompensated HF or HF-related congestion defined by at least one of the following qualifying event types: HF hospitalization, elevated BNP/NT-proBNP

排除标准

  • Subject has history of heart transplant or durable mechanical circulatory device
  • Subject hospitalized with cardiogenic shock or sepsis
  • Subject received prior PA pressure sensor implant (control arm only)

结局指标

主要结局

HF Hospitalization Rate.

时间窗: 2 years

Compare HF hospitalization rate between the treatment and control groups.

次要结局

  • Two-Year Survival(2 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验